Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
[Anticholinergics do not affect the sexual function in women diagnosed with multiple sclerosis].
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Testosterone Depletion Increases the Susceptibility of Brain Tissue to Oxidative Damage in a Restraint Stress Mouse Model.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Central Nervous System Infections With Immunomodulatory Therapies.
Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Autoantigens and autoantibodies in multiple sclerosis.
Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
[Natalizumab as induction therapy in multiple sclerosis.]
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Reduction in the free radical status and clinical benefit of repeated intrathecal triamcinolone acetonide application in patients with progressive multiple sclerosis.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
Sexual disorders in women with MS: Assessment and management.
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
Subacute sclerosing panencephalitis presenting as neuromyelitis optica.
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Association of Mycobacterium avium subsp. paratuberculosis and SLC11A1 polymorphisms in Sardinian multiple sclerosis patients.
Abnormalities of cerebral blood flow in multiple sclerosis: A pseudocontinuous arterial spin labeling MRI study.
Botulinum Toxin-What Urologic Uses Does the Data Support?
Reimbursement and market access of multiple sclerosis products in the United States.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Pages
« first
‹ previous
…
442
443
444
445
446
447
448
449
450
…
next ›
last »